egtazic acid has been researched along with Polycystic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvet, JP; Grantham, JJ; Hempson, SJ; Magenheimer, BS; Wallace, DP; Yamaguchi, T | 1 |
| Basora, N; Brown, EM; Chen, XZ; Hediger, MA; Nomura, H; Peng, JB; Reeders, ST; Segal, Y; Vassilev, PM; Zhou, J | 1 |
2 other study(ies) available for egtazic acid and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.
Topics: Animals; Blotting, Western; Calcimycin; Calcium; Calcium Channel Blockers; Cell Division; Cell Line; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Epithelial Cells; Humans; Ionophores; Kidney; Membrane Proteins; Mice; Mitogen-Activated Protein Kinases; Models, Biological; Phenotype; Phosphatidylinositol 3-Kinases; Polycystic Kidney Diseases; Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Time Factors; Transfection; TRPP Cation Channels; Verapamil | 2004 |
Polycystin-L is a calcium-regulated cation channel permeable to calcium ions.
Topics: Animals; Calcium; Calcium Channels; Calcium Signaling; Cations, Divalent; Cell Membrane Permeability; Chelating Agents; Cloning, Molecular; Egtazic Acid; Electrophysiology; Humans; Membrane Glycoproteins; Patch-Clamp Techniques; Phosphoproteins; Polycystic Kidney Diseases; Receptors, Cell Surface; Recombinant Proteins; Thapsigargin; Xenopus | 1999 |